ANEB vs BA · $15.3M cap vs P/E 89, rev $89.46B
Anebulo Pharmaceuticals Inc (ANEB) versus The Boeing Company (BA) — a side-by-side from cached financials, not a winner call.
Anebulo Pharmaceuticals Inc (ANEB) is a biotechnology company listed on US.
The Boeing Company (BA) is a aerospace & defense company listed on NYSE. It is led by Kelly Ortberg.
ANEB does not have a complete income-statement cache yet.
Latest reported BA revenue for 2025-12-31 was $89.46B. Net income was $2.23B. Revenue was up 34.5% from 2024-12-31 to 2025-12-31. BA currently screens at market cap $177.86B and trailing P/E 89.2.
ANEB currently screens at market cap $15.3M. BA currently screens at market cap $177.86B and trailing P/E 89.2.
Not investment advice. Open the ANEB and BA stock pages for the full models.
Not investment advice.